MX2024012192A - Formas de sal y solvatos de antagonistas de mci-1 - Google Patents

Formas de sal y solvatos de antagonistas de mci-1

Info

Publication number
MX2024012192A
MX2024012192A MX2024012192A MX2024012192A MX2024012192A MX 2024012192 A MX2024012192 A MX 2024012192A MX 2024012192 A MX2024012192 A MX 2024012192A MX 2024012192 A MX2024012192 A MX 2024012192A MX 2024012192 A MX2024012192 A MX 2024012192A
Authority
MX
Mexico
Prior art keywords
salt
sup
mci
solvates
antagonists
Prior art date
Application number
MX2024012192A
Other languages
English (en)
Spanish (es)
Inventor
Henry Morrison
Jason S Tedrow
Stephan D Parent
Courtney Johnson
Travis Houston
Melanie Bevill
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2024012192A publication Critical patent/MX2024012192A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX2024012192A 2022-04-05 2024-10-02 Formas de sal y solvatos de antagonistas de mci-1 MX2024012192A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263327659P 2022-04-05 2022-04-05
PCT/US2023/017504 WO2023196360A1 (en) 2022-04-05 2023-04-05 Salt forms and solvates of mci-1 antagonists

Publications (1)

Publication Number Publication Date
MX2024012192A true MX2024012192A (es) 2024-11-08

Family

ID=86386785

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024012192A MX2024012192A (es) 2022-04-05 2024-10-02 Formas de sal y solvatos de antagonistas de mci-1

Country Status (9)

Country Link
US (1) US12351588B2 (enExample)
EP (1) EP4504737A1 (enExample)
JP (1) JP2025513774A (enExample)
AU (1) AU2023249146A1 (enExample)
CA (1) CA3254998A1 (enExample)
MX (1) MX2024012192A (enExample)
TW (1) TW202404983A (enExample)
UY (1) UY40217A (enExample)
WO (1) WO2023196360A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4519271A1 (en) 2022-05-04 2025-03-12 Gilead Sciences, Inc. Salts and polymorphs of certain mcl-1 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3474B1 (ar) 2014-08-29 2020-07-05 Amgen Inc مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1

Also Published As

Publication number Publication date
CA3254998A1 (en) 2023-10-12
US20230312602A1 (en) 2023-10-05
TW202404983A (zh) 2024-02-01
JP2025513774A (ja) 2025-04-30
US12351588B2 (en) 2025-07-08
AU2023249146A1 (en) 2024-10-10
WO2023196360A1 (en) 2023-10-12
EP4504737A1 (en) 2025-02-12
UY40217A (es) 2023-10-31

Similar Documents

Publication Publication Date Title
US10851110B2 (en) Heterocyclic inhibitors of PTPN11
AU2012212196B2 (en) Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
MX2024012192A (es) Formas de sal y solvatos de antagonistas de mci-1
AU2014287471C1 (en) Fused piperidine amides as modulators of ion channels
DK2350090T3 (en) Spiro-oxindole compounds and their use as therapeutic agents
US8598164B2 (en) Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
RU2018111459A (ru) Гетероциклические соединения и их применение
EP3668839A1 (en) Heterocyclic inhibitors of atr kinase
WO2017156397A1 (en) Heterocyclic inhibitors of ptpn11
AU2020261423B2 (en) Heterocyclic inhibitors of tyrosine kinase
EP2609082A1 (de) Imidazo [4,5-c]chinoline als dna-pk-inhibitoren
PH12014502133B1 (en) Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
GEP20247627B (en) Macrocyclic compounds as sting agonists and methods and uses thereof
PH25493A (en) 2,3,4,5-tetrahydro-2-£(imidazol-(or-5)-yl)methyl-ih-pyrido£4,3-b|indol-1-ones , derivatives having 5-ht antagonist activity 3
KR102634732B1 (ko) 마크로시클릭 화합물 및 그의 용도
AU2014220838A1 (en) Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines
WO2016004418A1 (en) Glutaminase inhibitor therapy
AU2021200147A1 (en) Substituted benzimidazoles, their preparation and their use as pharmaceuticals
WO2008046084A2 (en) Spiroheterocyclic compounds and their uses as therapeutic agents
ES2141922T3 (es) Tiazepinonas de benzotiofeno, benzofurano e indol, oxazepinonas y diazepinonas usadas como inhibidores de la adherencia celular y del vih.
WO2013067248A1 (en) Benzoxazines as modulators of ion channels
CN111225903A (zh) 谷氨酰胺酶抑制剂疗法
ES2107212T3 (es) Derivados de 1,4-benzoxazina como abridores de los canales de potasio.
WO2023212549A1 (en) Tricyclic pyridones and pyrimidones
WO2005105753A8 (en) Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom